Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24

Abstract

Prostate cancer is the most prevalent noncutaneous cancer in males in developed regions, with African American men having among the highest worldwide incidence and mortality rates. Here we report a second genetic variant in the 8q24 region that, in conjunction with another variant we recently discovered, accounts for about 11%-13% of prostate cancer cases in individuals of European descent and 31% of cases in African Americans. We made the current discovery through a genome-wide association scan of 1,453 affected Icelandic individuals and 3,064 controls using the Illumina HumanHap300 BeadChip followed by four replication studies. A key step in the discovery was the construction of a 14-SNP haplotype that efficiently tags a relatively uncommon (2%-4%) susceptibility variant in individuals of European descent that happens to be very common (approximately 42%) in African Americans. The newly identified variant shows a stronger association with affected individuals who have an earlier age at diagnosis.

Whole-genome association study of bipolar disorder

“…5,6 Candidate gene studies while implicating several genes, 7 have only been able to focus on a minority of genes in the genome, and the interpretation of replication of individual findings has been difficult. Furthermore, strong support for applying a whole genome approach to BP disorder comes from the success in finding novel, strong and consistent susceptibility loci in type 2 diabetes, [8][9][10] prostate cancer, 11 Crohn's disease, 12 breast cancer 13 and coronary artery disease 14 using similar whole genome approaches. Like BP disorder, these diseases have a clear genetic component.…”

Variants at IRX4 as prostate cancer expression quantitative trait loci

“…[1][2][3][4][5][6][7][8][9][10] One of the current major challenges is to understand the underlying biology behind these association signals. Unlike most genetic effectors of Mendelian diseases, the majority of GWAS-discovered risk variants tend to lie within intronic, intergenic, or gene desert regions.…”

Molecular Epidemiology of Primary Brain Tumors

“…6 Recently, genome-wide association studies (GWAS) with very large sample sizes and carefully matched controls have provided a powerful tool to identify genes involved in common human genetic diseases. [7][8][9][10][11] This emergent technology can detect effects at the single nucleotide level. The identification of susceptibility alleles provides a greater understanding of carcinogenesis, potentially offering targets for therapeutic interventions.…”